Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hereditary Cancer Testing Market - By Diagnosis Type
1.3.2 Global Hereditary Cancer Testing Market - By Technology
1.3.3 Global Hereditary Cancer Testing Market - By End User
1.3.4 Global Hereditary Cancer Testing Market - By Geography

2. Global Hereditary Cancer Testing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Hereditary Cancer Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
4.4 Hereditary Cancer Testing - Price Analysis (US$)
4.5 Reimbursement Scenario (US)
4.6 Population Screening Data

5. Global Hereditary Cancer Testing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Hereditary Cancer
5.1.2 Growing Awareness About Hereditary Cancer
5.2 Key Market Restraints
5.2.1 Problems in Accessing Whole Genomic Data for Early Detection
5.3 Key Market Opportunities
5.3.1 Growing Demand for Noninvasive Methods of Detection
5.4 Future Trends
5.4.1 Preference For Personalized Medicines
5.5 Impact Analysis

6. Hereditary Cancer Testing Market - Global Analysis
6.1 Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis
6.2 Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Hereditary Cancer Testing Market Analysis- by Diagnosis Type
7.1 Overview
7.2 Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)
7.3 Biopsy Market
7.3.1 Overview
7.3.2 Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Blood Sample Market
7.3.3.1 Overview
7.3.3.2 Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Cheek Swab Sample Market
7.3.4.1 Overview
7.3.4.2 Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Imaging Market
7.4.1 Overview
7.4.2 Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Hereditary Cancer Testing Market Analysis- by Technology
8.1 Overview
8.2 Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
8.3 Sequencing Market
8.3.1 Overview
8.3.2 Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Polymerase Chain Reaction (PCR) Market
8.4.1 Overview
8.4.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Microarray Market
8.5.1 Overview
8.5.2 Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Hereditary Cancer Testing Market Analysis - by End User
9.1 Overview
9.2 Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
9.3 Diagnostic Centers Market
9.3.1 Overview
9.3.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Clinics Market
9.5.1 Overview
9.5.2 Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

10. Hereditary Cancer Testing Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Hereditary Cancer Testing Market
10.1.1 Overview
10.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Hereditary Cancer Testing Market
10.2.1 Overview
10.2.2 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.3 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.3.1 Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.4 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.5 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.6 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.2.7 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.7.2.1 UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.7.3 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.7.4 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.8 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.1 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.8.2.1 Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.8.3 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.8.4 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.9 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.9.2.1 France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.9.3 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.9.4 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.10 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.11 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Hereditary Cancer Testing Market
10.3.1 Overview
10.3.2 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.3.1 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.4 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.5 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.6 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.1 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.2 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.7.2.1 China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.7.3 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.7.4 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.8 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.2 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.8.2.1 India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.8.3 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.8.4 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.9 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.1 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.2 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.9.2.1 Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.9.3 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.9.4 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.10 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.11 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Hereditary Cancer Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.3.1 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.4 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.5 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.6 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.4.7 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.2 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.7.2.1 South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.7.3 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.7.4 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.8 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.1 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.8.2.1 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.8.3 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.8.4 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.9 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.2 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.9.2.1 UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.9.3 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.9.4 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Hereditary Cancer Testing Market
10.5.1 Overview
10.5.2 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.3.1 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.4 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.5 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.6 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.5.7 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.1 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.2 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.7.2.1 Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.7.3 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.7.4 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.8 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.2 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.8.2.1 Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.8.3 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.8.4 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Hereditary Cancer Testing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Product Launch
11.3.3 Product Approval
11.3.4 Others
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.4.2 Partnership
11.4.3 Agreement & Collaboration
11.4.4 Acquisition

12. Hereditary Cancer Testing Market-Key Company Profiles
12.1 Hologic Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Koninklijke Philips N.V.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Quest Diagnostics Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Myriad Genetics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cancer Genetics Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Invitae Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myogenes
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Strand Life Sciences Pvt. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Pathway Genomics Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 CENTOGENE AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms



List of Figures


Figure 1. Hereditary Cancer Testing Market Segmentation
Figure 2. Hereditary Cancer Testing Market Segmentation, by Region
Figure 3. Global Hereditary Cancer Testing Market Overview
Figure 4. Imaging Segment Held Largest Share Of The Diagnosis Type Segment In Hereditary Cancer Testing Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Hereditary Cancer Testing Market, By Geography (US$ Mn)
Figure 7. Global Hereditary Cancer Testing Market- Leading Country Markets (US$ Mn)
Figure 8. Global Hereditary Cancer Testing Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Hereditary Cancer Testing Market
Figure 15. Global Hereditary Cancer Testing Market - Revenue Forecasts and Analysis - 2018- 2027
Figure 16. Global Hereditary Cancer Testing Market - by Geography Forecasts and Analysis - 2018- 2027
Figure 17. Prominent Players in the Hereditary Cancer Testing Market
Figure 18. Global Hereditary Cancer Testing Market, by Diagnosis Type 2018 & 2027 (%)
Figure 19. Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Hereditary Cancer Testing Market, by Technology 2018 & 2027 (%)
Figure 24. Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Hereditary Cancer Testing Market, by End User 2018 & 2027 (%)
Figure 28. Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. North America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 32. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 34. US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Europe Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 38. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 40. UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Asia Pacific Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 46. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 48. China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Middle East & Africa Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 54. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 56. South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. South and Central America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 60. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 62. Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 64. Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 65. Organic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 66. Inorganic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019


List of Tables


Table 1. CPT Codes for Hereditary Cancer Tests
Table 2. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 3. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 4. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 5. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 6. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 7. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 8. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 9. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 10. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 11. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 12. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 13. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 14. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 15. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 16. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 17. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 18. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 19. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 20. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 21. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 22. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 23. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 24. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 25. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 26. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 27. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 28. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 29. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 30. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 31. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 32. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 33. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 34. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 35. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 36. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 37. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 38. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 39. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 40. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 41. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 42. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 43. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 44. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 45. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 46. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 47. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 48. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 49. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 50. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 51. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 52. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 53. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 54. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 55. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 56. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 57. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 58. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 59. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 60. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 61. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 62. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 63. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 64. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 65. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 66. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 67. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 68. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 69. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 70. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 71. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 72. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 73. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 74. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 75. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 76. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 77. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 78. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 79. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 80. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 81. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 82. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 83. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 84. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 85. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 86. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 87. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 88. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 89. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 90. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 91. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 92. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 93. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 94. Recent Product Launch in the Hereditary Cancer Testing Market
Table 95. Recent Product Approval in the Hereditary Cancer Testing Market
Table 96. Recent Other Growth Strategies in the Hereditary Cancer Testing Market
Table 97. Partnerships in the Hereditary Cancer Testing Market
Table 98. Agreement & Collaboration in the Hereditary Cancer Testing Market
Table 99. Acquisitions in the Hereditary Cancer Testing Market
Table 100. Glossary of Terms, Hereditary Cancer Testing Market